Early Interventions for Treating Influenza: Economic Evaluation in Managed Care Settings

Date:               Tuesday, April 30, 2019

Location:         Wynn and Encore Hotels
3131 S Las Vegas Boulevard
Las Vegas, Nevada 89109

Room: Lafleur

Time:               12:00 pm – 1:30 pm
                        *Lunch will be available

Program Description
Influenza is a highly contagious acute respiratory infection caused by influenza viruses A, B, or C. Vaccinations offer the opportunity of protection against influenza, but the rate of vaccination in the United States is suboptimal. Antiviral medications have proven to be effective for the prevention of influenza and can reduce the severity and duration of the flu when used as treatment. Managed care professionals, including pharmacists, should be aware of the treatments available for the prevention and management of influenza as well as the gravity of related complications, especially in high-risk patient populations. Additionally, they should understand the significance of initiating treatment early with antiviral therapy to prevent or reduce the incidence of flu-related complications.

Educational Objectives
  • Identify the economic burden of influenza
  • Illustrate the complications and disease burden that can be prevented with early intervention
  • Examine the clinical evidence associated with approved agents for the treatment of influenza
  • Analyze economic data to appropriately manage influenza

Faculty Presenters

Marilyn Bulloch, PharmD, BCPS, FCCM
Associate Clinical Professor and Director of Strategic Operations
Harrison School of Pharmacy, Auburn University
Kimberly, Alabama

Sheldon J. Rich, RPh, PhD
SJR Associates, LLC
Sarasota, Florida
Adjunct Clinical Assistant Professor
University of Michigan
Ann Arbor, Michigan

This activity is supported by an educational grant from Genentech. 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-046-L01-P. The activity is available for CE credit for April 30, 2019.

Obtaining Credit:
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Detailed instructions on obtaining credit will be provided at the session. Credit must be requested no later than June 30, 2019.